DaVita Inc (DVA)

105.64 +1.82  +1.75% NYSE Mar 5, 16:59 USD
View Full Chart
Price Chart
View All DVA News

News

View All Events

Events

Date Type Description
05/05/2021 Earnings DaVita Inc First Quarter Earnings Results for 2021
05/05/2021 Misc DaVita Inc First Quarter Earnings Conference Call for 2021
02/11/2021 Earnings DaVita Inc Fourth Quarter Earnings Result for 2020
02/11/2021 17:00 EST Misc DaVita Inc Fourth Quarter Earnings Conference Call for 2020
10/29/2020 Earnings DaVita Inc Third Quarter Earnings Result for 2020
10/29/2020 17:00 EDT Misc DaVita Inc Third Quarter Earnings Conference Call for 2020
07/30/2020 17:00 EDT Misc DaVita Inc Second Quarter Earnings Conference Call for 2020
07/30/2020 Earnings DaVita Inc Second Quarter Earnings Result for 2020
06/11/2020 10:00 MDT Misc DaVita Inc Annual General Meeting for 2019
05/05/2020 17:00 EDT Misc DaVita Inc First Quarter Earnings Conference Call for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.davita.com
  • Investor Relations URL: http://investors.davita.com/phoenix.zhtml?c=76556&p=irol-irHome
  • HQ State/Province: Colorado
  • Sector: Healthcare
  • Industry: Medical Care Facilities
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: May. 05, 2021
  • Last Earnings Release: Feb. 11, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: DaVita is the largest provider of dialysis services in the United States, boasting a market share that eclipses 35% when measured by both patients and clinics. The firm operates about 3,000 facilities worldwide, mostly in the U.S., and treats over 235,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Top Fund Holders

Symbol Name Weighting
FOUSA06MSW JNL/Goldman Sachs Intrinsic Value A 3.97%
FOUSA06MSX JNL/Goldman Sachs Total Yield A 3.89%
FXH First Trust Health Care AlphaDEX® ETF 1.80%
ZUH.TO BMO Eq Wght US HlthCare Hdgd to CAD ETF 1.67%
PKW Invesco BuyBack Achievers ETF 1.61%
RPG Invesco S&P 500® Pure Growth ETF 1.58%
GTLIX Glenmede Quant US Large Cap Core EqInstl 1.55%
IHF iShares US Healthcare Providers ETF 1.34%
SUWUX DWS Core Equity T 1.32%
BWLAX American Beacon Bridgeway Lg Cp Val A 1.06%
VSEQX Vanguard Strategic Equity Inv 0.74%
OMFL Invesco Russell 1000® Dynamic Mltfct ETF 0.44%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.